SEC Form DEF 14A filed by Applied DNA Sciences Inc.
SECURITIES AND EXCHANGE COMMISSION
of the Securities Exchange Act of 1934
(Amendment No. )
50 HEALTH SCIENCES DRIVE
STONY BROOK, NEW YORK 11790
(631) 240-8800
| | | | Very truly yours, | |
| | | |
/s/ James A. Hayward
James A. Hayward
Chairman, President and Chief Executive Officer |
|
| | | | Very truly yours, | |
| | | |
/s/ James A. Hayward
James A. Hayward
Chairman, President and Chief Executive Officer |
|
June 21, 2024
for the Special Meeting of Stockholders
To Be Held on August 2, 2024
| | | | | 1 | | | |
| | | | | 1 | | | |
| | | | | 7 | | | |
| | | | | 11 | | | |
| | | | | 12 | | | |
| | | | | 13 | | | |
| | | | | 14 | | |
50 HEALTH SCIENCES DRIVE
STONY BROOK, NEW YORK 11790
APPROVAL, IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(D), OF THE EXERCISABILITY OF CERTAIN COMMON STOCK PURCHASE WARRANTS, AND THE ISSUANCE OF THE COMMON STOCK UNDERLYING SUCH WARRANTS, WHICH WARRANTS WERE ISSUED IN CONNECTION WITH AN OFFERING OF SECURITIES OF THE COMPANY THAT OCCURRED ON MAY 28, 2024
| | |
Title of Class
|
| |
Number of
Shares Owned(1) |
| |
Percentage
of Class(2) |
| | ||||||||
Executive Officers and Directors: | | | | | | | | | | | | | | | | | | | |
James A. Hayward
|
| |
Common Stock
|
| | | | 25,324(3) | | | | | | * | | | | ||
Yacov A. Shamash
|
| |
Common Stock
|
| | | | 8,994(4) | | | | | | * | | | | ||
Robert B. Catell
|
| |
Common Stock
|
| | | | 8,436(8) | | | | | | * | | | | ||
Joseph D. Ceccoli
|
| |
Common Stock
|
| | | | 8,554(5) | | | | | | * | | | | ||
Beth M. Jantzen
|
| |
Common Stock
|
| | | | 6,922(9)(12) | | | | | | * | | | | ||
Judith Murrah
|
| |
Common Stock
|
| | | | 7,763(10)(12) | | | | | | * | | | | ||
Clay Shorrock
|
| |
Common Stock
|
| | | | 6,377(12)(13) | | | | | | * | | | | ||
Sanford R. Simon
|
| |
Common Stock
|
| | | | 8,356(6) | | | | | | * | | | | ||
Elizabeth Schmalz Shaheen
|
| |
Common Stock
|
| | | | 8,373(11) | | | | | | * | | | | ||
All directors and officers as a group (9 persons)
|
| |
Common Stock
|
| | | | 89,099(7) | | | | | | 1.00% | | | | ||
5% Stockholder: | | | | | | | | | | | | | | | | | | ||
Leviticus Partners, L.P.
|
| |
Common Stock
|
| | | | 571,232(14) | | | | | | 6.34% | | | | ||
L1 Capital Global Opportunities Master Fund, Ltd.
|
| |
Common Stock
|
| | | | 900,284(15) | | | | | | 9.99% | | | | ||
S.H.N. Financial Investments Ltd.
|
| |
Common Stock
|
| | | | 900,284(16) | | | | | | 9.99% | | | |
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
Applied DNA Sciences, Inc.
50 Health Sciences Drive
Stony Brook, New York 11790
Chairman, President and Chief Executive Officer
June 21, 2024